Previous 10 | Next 10 |
JACKSON CENTER, PA / ACCESSWIRE / July 16, 2020 / Halberd Corp. (OTC PINK: HALB ) intends to use laser technology to eradicate the COVID-19 Coronavirus. This patent pending treatment introduces one or more fluorescent antibody-antigen complexing agents to bind with the target antigen(s) (i.e...
JACKSON CENTER, PA / ACCESSWIRE / July 13, 2020 / Halberd Corp. (OTC PINK: HALB ) today issued a statement to clarify certain items within its charter regarding allowable debt. There have been inaccurate rumors that have put the company in a negative light. One of these is that the company i...
JACKSON CENTER, PA / ACCESSWIRE / July 7, 2020 / Halberd Corp. (OTC PINK: HALB ) today explains the second of three (3) COVID -19 (Coronavirus) patent pending treatments - "Method for Treating Covid-19 Inflammatory Cytokine Storm for the Reduction of Morbidity and Mortality in Covid-19 Patie...
JACKSON CENTER, PA / ACCESSWIRE / June 29, 2020 / Halberd Corporation (OTC PINK: HALB ) today unveils the first of three (3) COVID -19 (Coronavirus) patent pending treatment methods - the first titled, "Method for Treating and Curing Covid-19 Infection" - filed with the U.S. Patent and Trade...
JACKSON CENTER, PA / ACCESSWIRE / J une 22, 2020 / Halberd Corporation (OTC PINK: HALB ) announced the appointment of Dr. Patricio F. Reyes to the position of Chief Technical Officer effective immediately. He will report to Halberd's new Chairman, President and CEO, William A. Hartman and i...
Halberd Designated "Pink Current Information" by OTC and Continues Technology Progress JACKSON CENTER, PA / ACCESSWIRE / June 15, 2020 / Halberd Corporation (OTC PINK: HALB ) announced that OTC Markets has completed its background investigation and analysis of all filings by Halberd Cor...
JACKSON CENTER, PA / ACCESSWIRE / June 9, 2020 / Halberd Corporation (OTC PINK: HALB ) announced the appointment of Dr. Patricio F. Reyes to its Scientific Advisory Board effective immediately He will report to Halberd's Chairman, President and CEO, William A. Hartman. Dr. Reyes, MD, FAAN, ...
Halberd is Also Now Fully Compliant With OTC Market Reporting Requirements And Plans to Immediately Develop Covid-19 Treatment JACKSON CENTER, PA / ACCESSWIRE / June 5, 2020 / Halberd Corporation (OTC PINK: HALB ), formerly Technology Health Inc., today issued a clarification/correc...
JACKSON CENTER, PA / ACCESSWIRE / June 3, 2020 / Technology Health, Inc. (OTC PINK: HALB ) formerly Halberd Corp., announced that it is now fully compliant with OTC Market reporting requirements. William A. Hartman, newly-appointed Chairman, President and CEO of Technology Health, Inc, stat...
JACKSON CENTER, PA / ACCESSWIRE / May 12, 2020 / Premier Biomedical, Inc. (OTC PINK: BIEI ) and Technology Health, Inc. (OTC PINK: HALB ) announced today an agreement to pursue a novel coronavirus extracorporeal treatment which combines Premier Biomedical's antigen mapping technique with D...
News, Short Squeeze, Breakout and More Instantly...
Walt Disney once said, "All our dreams can come true if we have the courage to pursue them". JACKSON CENTER, PA / ACCESSWIRE / May 22, 2024 / Halberd Corporation (OTC PINK:HALB) in cooperation with Athena GTX, Inc is standing at the threshold of some major advancements to treat the issues ...
Daniel J. Harvey and Adam Lambert Improving Servicemember Transition to Reduce Veteran Suicide Act, passed the U.S. House unanimously. JACKSON CENTER, PA / ACCESSWIRE / May 9, 2024 / Halberd Corporation's (OTC PINK:HALB) two active programs for the treatment and mitigation of the negative ...
LDN+ Drug Designed to Combat PTSD and Suicidal Ideation JACKSON CENTER, PA / ACCESSWIRE / April 30, 2024 / Halberd Corporation (OTC PINK:HALB) announced a pre-pilot study of its patented LDN+ drug with military volunteers has now begun with limited participants but is currently expected to...